Skip to main content

Current Issue

December 2019

Volume 12 Issue 16
Interviews
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Endovascular Techniques
VASCULAR DISEASE MANAGEMENT 2019;16(7):E179-E182.
Vlad Adrian Alexandrescu, MD, PhD1; Arnaud Kerzmann, MD2; Ross Melvin, DO3; Augustin Limgba, MD3 1 Department / Thoracic and Vascular Surgery, Princess Paola Hospital, Marche-en-Famenne, IFAC-Vivalia,Belgium; Consultant in the Cardio-Vascular and Thoracic Department, CHU Sart-Tilman Hospital, Liège, Belgium.  2Department / Thoracic and Cardio-Vascular Surgery, CHU Sart-Tilman Hospital, Liège, Belgium. 3Department / Interventional Cardiology, Cardiovascular Institute of the South, Houma, Louisiana 4Department / Thoracic and Vascular Surgery, Princess Paola Hospital, Marche-en-Famenne, IFAC-Vivalia, Belgium
Alexandrescu and colleagues review the main anatomical features describing infra-popliteal arterial vasculature with, and without, ischemic impairment, in accordance with practical clinical issues encountered in daily practice.
Case Report
VASCULAR DISEASE MANAGEMENT 2019;16(12):E170-E173.
Mason D. Nagel, BS,1 and George Adams, MD, MHS, FACC2  1NCSU of Raleigh, North Carolina 2UNC Rex Hospital of Raleigh, North Carolina 
Nagel and Adams describe a case that utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.
Endovascular Techniques
VASCULAR DISEASE MANAGEMENT 2019;16(12):E174-E176.
Joseph J. Ingrassia, MD, Matthew T. Finn, MD, Sahil A. Parikh, MD  Center for Interventional Vascular Therapy New York-Presbyterian Hospital Columbia University Irving Medical Center Columbia University Vagelos College of Physicians and Surgeons, New York, New York
Parikh and colleagues discuss the recently released Global Vascular Guidelines and important new concepts emanating from these guidelines.
Original Research
VASCULAR DISEASE MANAGEMENT 2019;16(12):E166-E169.
Johanes Nugroho, MD, PhD,1,2 Risa Titis Wijayanti, MD1,2 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia  2Dr Soetomo General Hospital, Surabaya, Indonesia 
Nurgroho and colleagues describe how home-based exercise training improved VEGF level and ABI in patients with PAD.
Editor's Corner
VASCULAR DISEASE MANAGEMENT 2019;16(12):E165.
Dr. Walker comments on a pilot study by Nugroho and colleagues, and how home-based exercise training may increase levels of VEGF in patients with mild PAD.
Interviews
VASCULAR DISEASE MANAGEMENT 2019;16(12):E185-E186.
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
Back to Top